Abstract:569 Background: Obesity, a prominent issue in global health, is known to increase the risk factors associated with a variety of cancers, including hepatocellular carcinoma (HCC), the most common type of primary liver cancer. While existing research affirms the heightened risk of developing HCC in individuals with obesity, there remains a significant gap in understanding the specific influences of obesity on the outcomes of patients admitted with primary HCC diagnosis during their index hospital admission. This study explores the mortality rate, length of stay (LOS), and healthcare utilization in HCC patients with and without obesity. Methods: Nationwide Inpatient Sample (NIS) was queried to determine adult hospitalized patients with a primary diagnosis of HCC using ICD-10 codes. The primary outcome was defined as the effect of obesity on inpatient mortality in those patients. Secondary outcomes included LOS, total hospital charge, health care utilization, ICU admission. We evaluated the baseline characteristics using the t-test and chi-square test. Multivariable logistic regression analysis was performed to assess the association of HCC with obesity and inpatient mortality adjusted by age, gender, race, Charlson index, insurance, and household income. Results: A total of 62,050 HCC patients were identified, and 10.9% of these patients had obesity. HCC patients with obesity were younger (64.7 vs. 65 years, p=0.220), more likely to be female (32.2% vs. 24%, p < 0.001), White (59.8% vs. 50.2% p < 0.001), and more likely to have no insurance (28.8% vs. 23.3%, p < 0.001) compared to HCC patients without obesity. HCC with obesity had higher mean Charlson Comorbidity index 5.9 vs. 5.5, p < 0.001). The overall inpatient mortality rate was 8.2% for all patients who are admitted for HCC; lower in HCC with obesity (5.6%) vs HCC without obesity (8.5%) (p < 0.001). Charlson index, Male gender, African–American race, Hospital teaching status, insurance status found to be associated with inpatient mortality among HCC hospitalizations. HCC with obesity had a lower odds ratio with decreased all-cause mortality of 25% compared to HCC without obesity (aOR 0.75, 95% CI 0.58-0.96, p = 0.023). In addition, HCC with obesity was associated with increased LOS mean 6.3 vs. 5.7 days (adjusted difference: 0.6 p < 0.001), and total hospital charges (mean 88,481, adjusted difference: $21122 p < 0.0001). Also; ICU transfer rate and AKI development were found more in obese cohort and this different was statistically significant. Conclusions: Our study revealed that HCC patients with obesity had a lower inpatient mortality rate compared to those without obesity, despite longer hospital stays and higher costs. These findings hint at a complex interplay between obesity and HCC outcomes, necessitating further in-depth research.

The effect of oral contraceptive pill cessation on hepatocellular adenoma diameter: A retrospective cohort study

Body weight changes and duration of estrogen exposure modulate the evolution of hepatocellular adenomas after contraception discontinuation

Regression of hepatocellular adenoma after bariatric surgery in severe obese patients

KETOgenic diet therapy in patients with HEPatocellular adenoma: study protocol of a matched interventional cohort study

A multicentre retrospective analysis on growth of residual hepatocellular adenoma after resection

Reproductive factors, exogenous hormone use and risk of hepatocellular carcinoma among US women: results from the Liver Cancer Pooling Project

[Effects of Pathological Assessment of Endometrial Tissue in Fertility-Sparing Treatment with Progestin for Endometrial Carcinoma of Stage I a and Complex Atypical Hyperplasia].

The association between oral contraceptive pills and ovarian cancer risk: A systematic review and meta-analysis

Risk factors for bleeding hepatocellular adenoma in a United States cohort

Bilateral oophorectomy and the risk of hepatocellular carcinoma in women with hepatitis C: A population-based study

Combined Estrogen-Progestin Pill Is A Safe And Effective Option For Endometrial Hyperplasia Without Atypia: A Three-Year Single Center Experience

The Effect of the Oral Contraceptive Pill on Acute Glycaemic Response to an Oral Glucose Bolus in Healthy Young Women: A Randomised Crossover Study

The effect of hormonal contraceptive therapy on clinical laboratory parameters: a literature review

Exogenous hormone use, reproductive factors and risk of intrahepatic cholangiocarcinoma among women: results from cohort studies in the Liver Cancer Pooling Project and the UK Biobank

The effect of obesity in hospitalized patients with hepatocellular carcinoma: A nationwide analysis.

The surgical, histopathological characteristics, and survival outcome of ovarian clear cell carcinoma: a retrospective case series sharing the experience of a tertiary cancer centre

Hepatic complications of oral contraceptive pills and estrogen on MRI: Controversies and update - Adenoma and beyond

Effects of hormone therapy on recurrence in endometrial cancer survivors: a nationwide study using the Korean Health Insurance Review and Assessment Service database

New insights in the management of Hepatocellular Adenoma

Hepatocellular adenoma: An unsolved diagnostic enigma

The Effect of Hormonal Treatment on Ovarian Endometriomas: A Systematic Review and Meta-Analysis